Gauss

Flt3 (human) recombinant protein 100 µg

Réf. UGAP : 3870894 Réf. Fournisseur : 16017916 Réf. Constructeur : P4695
Franco de port et d'emballage pour toutes les commandes supérieures à 80€ HT.

Produit ni repris ni échangé excepté en cas d’erreur du prestataire.
La quantité choisie doit être comprise entre 1 et 999 999.

Points clés

Used for Func, SDS-PAGE

This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq]

En savoir plus

Garantie

Garantie 0 Mois

Description

Used for Func, SDS-PAGE

This gene encodes a class III receptor tyrosine kinase that regulates hematopoiesis. The receptor consists of an extracellular domain composed of five immunoglobulin-like domains, one transmembrane region, and a cytoplasmic kinase domain split into two parts by a kinase-insert domain. The receptor is activated by binding of the fms-related tyrosine kinase 3 ligand to the extracellular domain, which induces homodimer formation in the plasma membrane leading to autophosphorylation of the receptor. The activated receptor kinase subsequently phosphorylates and activates multiple cytoplasmic effector molecules in pathways involved in apoptosis, proliferation, and differentiation of hematopoietic cells in bone marrow. Mutations that result in the constitutive activation of this receptor result in acute myeloid leukemia and acute lymphoblastic leukemia. [provided by RefSeq]

Caractéristiques

Fournisseur
FISHER SCIENTIFIC S.A.S.
Marque
ABNOVA
Référence fabricant
P4695
Référence distributeur
16017916
Vendu par
100 ug
Quantité
N/A
Lieu de fabrication
Taiwan
Lieu de stockage
France
Délai de péremption à la date de livraison
12 mois
Code à barre
non
Soumis à carboglace
oui
Libellé produit fabricant
100ug flt3 (human) recombinant protein
Certification
RUO
Marquage CE DIV
non
Type de produit
protéine
Type de protéine
oui
Type d'antibiotique
non
Type d'enzyme
non
Température de conservation (°C)
-80 °C
Température de transport
carboglace
Dispositif stérile
non
Type d'acide nucléique extrait
non
Origine humaine
non
Sans composant animal
non
Matière dangereuse
non
Autres caractéristiques
Abnova Human FLT3 (NM_004119, 571 a.a. - 993 a.a.) Partial Recombinant Protein with GST-His tag expressed in Sf9 cells, Format: Liquid, Formulation: Liquid, Host Species: Insect, Molecular Weight: 77.198kDa, Protein Tag: GST-His, Quantity: 100 ug,
Classification REACH
non
Code douanier
38229000
Nomenclature Nacres
NA.55
Nomenclature IFPEN
NA.55
Nomenclature CEA
SGP01
Nomenclature IRSN
273
Nomenclature INSERM
NA.NA55
Nomenclature CNRS
NA55
Nomenclature CHU
18.551
Nomenclature DGOS
LD10AOOO
Type d’application
ELISA, Western-Blot
Type d'échantillon
protéine
Reprise en cas d’erreur client
non
Domaine de recherche
protéomique